Amir Neshatfar

Amir Neshatfar practices at Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers.

Amir Neshatfar's NPI, 1821550831, was assigned on April 1, 2019. Amir Neshatfar holds Missouri license 2023002912.

Amir Neshatfar's primary practice is Cox Medical Center South, at 3801 South National Avenue, Springfield, MO 65807 in Greene County. The practice phone is (417) 269-6000.

Amir Neshatfar's primary practice is Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers. Amir Neshatfar is also affiliated with Freeman Hospital West. The medical group on file is CoxHealth Neurology. Dmand AI also links Amir Neshatfar to 2 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amir Neshatfar practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Amir Neshatfar's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Amir Neshatfar is licensed in Missouri.

Dmand AI lists cerebrovascular disease, seizures, sleep apnea and stroke among the conditions Amir Neshatfar treats.

CMS data shows 689 Medicare services from Amir Neshatfar across 7 procedure codes in 2024, for 358 Medicare patients. Medicare paid $66,217 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 358 Medicare patients who saw Amir Neshatfar in 2024. The largest group is 75 to 84, with 131 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amir Neshatfar's median patient age at 76, with 54% women.

In 2024, Amir Neshatfar wrote 88 Medicare Part D claims for 35 patients. 95% of them were for generic drugs. CMS names the drug for 43 of them, across 3 drugs with 11 or more claims each, at $390 in total drug cost. In 2023, CMS named 152 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Amir Neshatfar for performance year 2024, reported as part of a group. Amir Neshatfar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 24 general payments to Amir Neshatfar from 13 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. ANI Pharmaceuticals, Inc. paid the most, $590.

Amir Neshatfar is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.